🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06474338
Recruiting Observational

AI Detection of Bladder Tumors Under Endoscopy

NCT06474338 · tracked via the Priya Life Science China tracker
Sponsor
Peking Union Medical College Hospital
Phase
Observational
Started
2024-01-01
Last updated
2024-06-25

Condition(s) studied

Bladder Tumor

Investigational drug(s) / intervention(s)

detection by artificial intelligencedetection by urologists

detection by artificial intelligence: The bladder lesion(s) are detected by artificial intelligence algorithm.

detection by urologists: The bladder lesion(s) are detected by urologists.

Study summary

The goal of this clinical trial is to learn if the AI algorithm can detect bladder tumors better than urologists under cystoscopy. It will also train the AI algorithm for bladder tumor detection. The main question it aims to answer is:

Can AI algorithm achieve IOU value, precision, recall, false negative rate of bladder tumor detection similar to that of urologists? The cystoscopy video will be annotated by AI and urologists. Researchers will compare AI algorithm to urologists to see if Al algorithm has a similar capability as urologists do.

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: The patient who receives cystoscopy and the cystoscopy video is available, and one or multiple bladder lesions can be observed in the cystoscopy. Exclusion Criteria: The patient whose cystoscopy is not clear enough to analyze.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Peking Union Medical College Hospital Beijing Beijing Municipality Recruiting

More Peking Union Medical College Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06474338 on ClinicalTrials.gov ↗ ← All trials in China